Search Results
Outcomes of patients with monocytic AML treated with venetoclax & azacitidine
Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients ...
OMNIVERSE: safety and tolerability of oral azacitidine plus venetoclax in patients with AML
The importance of predicting venetoclax response in patients with AML
Azacitidine, venetoclax & gilteritinib in older/unfit patients with FLT3-mutated AML
Investigating the safety & efficacy of magrolimab, azacitidine & venetoclax in patients with AML
AML: options after venetoclax-based regimen failure
Phase I trial results for oral azacitidine and venetoclax in R/R AML
Venetoclax-based strategies in AML
Magrolimab plus azacitidine in treatment-naïve AML
Viale-A trial: Should azacitidine plus venetoclax become SoC for elderly patients with ND AML?
What do long-term data from the VIALE-A trial tell us about treatment with azacitidine + venetoclax?
